The over-expression of RARRES3 has been shown to reverse the tumour phenotype and conversely, RARRES3 expression seems suppressed in several different cancers including B-cell lymphocytic leukemia, breast and colorectal cancer [16, 34–40]. This evidence concerns the gene PLAAT4 and B-cell chronic lymphocytic leukemia.